Department of Orthopedics, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China.
Department of Ophthalmology, the Second Hospital of Hebei Medical University, Shijiazhuang 050061, China.
J Zhejiang Univ Sci B. 2021 Nov 15;22(11):885-892. doi: 10.1631/jzus.B2100029.
Osteosarcoma (OS) is the most common primary bone tumor in children and adolescents. It is an aggressive tumor with a tendency to spread to the lung, which is the most common site of metastasis. Patients with advanced OS with metastases have poor prognoses despite the application of chemotherapy, thus highlighting the need for novel therapeutic targets. The tumor microenvironment (TME) of OS is confirmed to be essential for and supportive of tumor growth and dissemination. The immune component of the OS microenvironment is mainly composed of tumor-associated macrophages (TAMs). In OS, TAMs promote tumor growth and angiogenesis and upregulate the cancer stem cell-like phenotype. However, TAMs inhibit the metastasis of OS. Therefore, much attention has been paid to investigating the mechanism of TAMs in OS development and the progression of immunotherapy for OS. In this article, we aim to summarize the roles of TAMs in OS and the major findings on the application of TAMs in OS treatment.
骨肉瘤(OS)是儿童和青少年中最常见的原发性骨肿瘤。它是一种具有侵袭性的肿瘤,倾向于扩散到肺部,这是最常见的转移部位。尽管应用了化疗,但患有转移性晚期 OS 的患者预后较差,因此需要新的治疗靶点。OS 的肿瘤微环境(TME)被证实对肿瘤生长和扩散至关重要且具有支持作用。OS 微环境中的免疫成分主要由肿瘤相关巨噬细胞(TAMs)组成。在 OS 中,TAMs 促进肿瘤生长和血管生成,并上调癌症干细胞样表型。然而,TAMs 抑制 OS 的转移。因此,人们非常关注研究 TAMs 在 OS 发展中的作用以及 TAMs 在 OS 治疗中的应用的主要发现。本文旨在总结 TAMs 在 OS 中的作用以及 TAMs 在 OS 治疗中的应用的主要发现。